Bruce C. Cozadd - Jan 17, 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Chairman & CEO, Director
Signature
By: /s/Paz Dizon, as attorney in fact For: Bruce C Cozadd
Stock symbol
JAZZ
Transactions as of
Jan 17, 2025
Transactions value $
-$1,697,061
Form type
4
Date filed
1/22/2025, 06:55 PM
Previous filing
Jan 6, 2025
Next filing
Feb 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +29.6K +6.95% $0.00 455K Jan 17, 2025 Direct F1
transaction JAZZ Ordinary Shares Tax liability -$1.7M -13.8K -3.04% $122.62 441K Jan 17, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified.
F2 Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.